Newsroom

Sorted by: Latest

-

Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans...
-

CyberArk獲得IDC MarketScape《2025年全球身分安全整合解決方案供應商評估》頒予「領導者」榮銜

麻薩諸塞州,紐頓 & 以色列,佩塔提克瓦--(BUSINESS WIRE)--(美國商業資訊)-- CyberArk (NASDAQ: CYBR ) 是身分安全的全球翹楚。該公司今天宣布獲得IDC MarketScape《2025年全球身分安全整合解決方案供應商評估》(Worldwide Integrated Solutions for Identity Security 2025) 頒予「領導者」榮銜。CyberArk透過其統一平台擴大動態權限控制及於所有身分類型,提高企業效率並簡化安全運作。 IDC MarketScape在這份報告中指出:「身分安全市場在過去兩年間發生的變化之多,近十年所未見。供應商正進入一個新階段,其不同之處是智慧技術興起,而且這些技術目前尚未接受任何產業標準的明確規範。儘管設計各有千秋,但這些新型身份和存取管理 (IAM) 解決方案主要側重於提高漏洞和威脅管理的可見性,以及自動化和預測性的攻擊偵測能力。」這份報告還指出:「CyberArk在統一框架內處理這些不斷變化的身份類型,增強大規模管理權限、降低營運複雜性、並在企業採用先進技術時保持安全連續性的能力。」...
-

Did You Lose Money in Your Blue Owl Capital Inc. Investment? Contact Robbins LLP for Information About Your Rights Against OWL.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of Blue Owl Capital Inc. (NYSE: OWL) investors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? February 6, 2025 – November 16, 2025 What are the Allegations? Robbins LLP is Investigating Allegations that Blue Owl Capital Inc. (OWL) Misled Investors Regarding its Business Prospects According to the complaint, du...
-

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous System Therapeutics was valued at US$107 Billion in 2024 and is projected to reach US$156.5 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. T...
-

Genentech Announces Agreement With U.S. Government

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced an agreement with the U.S. government that lowers costs for state Medicaid programs, encourages other wealthy countries to reward innovation, and increases opportunities for direct patient access. Under this agreement, Genentech is making commitments that address all four priorities set forth in the President’s July 31st letter. Genentech’s commitments include making many...
-

Growth Opportunities in the Maturing $4.7 Billion Electric Trucks Market, 2025-2032: Total Revenues to Reach $16.47 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electric Trucks Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The electric truck market is advancing rapidly, driven by sustainability imperatives, fleet modernization, and regulatory pressures. As electrification transforms commercial transportation, decision-makers must navigate evolving policy landscapes, supply chains, and innovative technologies to maintain leadership in a competitive environment. Electric Truc...
-

LBP Ventures Adds Majed Al Sorour as Special Advisor

HOUSTON--(BUSINESS WIRE)--LBP Ventures, LLC (“LBPV”) welcomes Majed Al Sorour as Special Advisor providing counsel to the fund’s management on strategy and investor engagement....
-

Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company’s long-standing commitment to U.S.-based innovation, affordability, and global health leadership. “This agreement reflects a foundational commitment to both affordability and future innovation, a commitment that we have long seen as essential to shaping the future of healthcare,” said Daniel O’Day, C...
-

Did You Lose Money in Your DeFi Technologies Inc. Investment? Contact Robbins LLP for Information About Your Rights Against DEFT.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: DeFi Technologies (NASDAQ:DEFT), formerly known as Valour Inc., purports to be a technology and digital asset treasury (“DAT”) company that develops exchange traded products in Canada that synthetically track the value of a single decentralized finance (“DeFi”) protocol—that is, a set of standards and rules that govern a system of lending, borrowing, and trading a cryptocurrency—or a basket of DeFi protocols. What is the class period? May 12, 20...
-

Strada Closes 2025 With Major Growth Milestones, a Strengthened Leadership Team and a Bold Vision for Innovation

THE WOODLANDS, Texas--(BUSINESS WIRE)--Strada today celebrates a series of major achievements and closes 2025 as a fully independent business with momentum and a clear path into 2026....